AbbVie raised its full-year adjusted earnings guidance and reported higher first-quarter revenue, boosted by growth in its immunology and neuroscience portfolios.
Source link
AbbVie Raises FY Guidance on Immunology, Neuroscience Growth
Date:
More like thisRelated
Motorcyclist killed in northeast Albuquerque crash
ALBUQUERQUE, N.M. (KRQE) – Albuquerque Police officers are investigating a...
Airbus to Get $3.42 Billion Loan From European Investment Bank in Tech Sovereignty Push
The financing will support the company’s investments in commercial...
Police say 5 people have died in a shooting in Stade in northern Germany
BERLIN -- Five people were killed in a shooting...